Home > Publications Database > Biomarker-Based Approach to α-Synucleinopathies: Lessons from Neuropathology. > print

001     275849
005     20250119000402.0
024 7 _ |a 10.1002/mds.30028
|2 doi
024 7 _ |a pmid:39360851
|2 pmid
024 7 _ |a pmc:PMC11657033
|2 pmc
024 7 _ |a 0885-3185
|2 ISSN
024 7 _ |a 1531-8257
|2 ISSN
024 7 _ |a altmetric:168919918
|2 altmetric
037 _ _ |a DZNE-2025-00084
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Kovacs, Gabor G
|0 0000-0003-3841-5511
|b 0
245 _ _ |a Biomarker-Based Approach to α-Synucleinopathies: Lessons from Neuropathology.
260 _ _ |a New York, NY
|c 2024
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1736766537_13802
|2 PUB:(DE-HGF)
|x Editorial
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
700 1 _ |a Grinberg, Lea T
|b 1
700 1 _ |a Halliday, Glenda
|0 0000-0003-0422-8398
|b 2
700 1 _ |a Alafuzoff, Irina
|b 3
700 1 _ |a Dugger, Brittany N
|b 4
700 1 _ |a Murayama, Shigeo
|b 5
700 1 _ |a Forrest, Shelley L
|b 6
700 1 _ |a Martinez-Valbuena, Ivan
|0 0000-0001-6463-6321
|b 7
700 1 _ |a Tanaka, Hidetomo
|b 8
700 1 _ |a Kon, Tomoya
|b 9
700 1 _ |a Yoshida, Koji
|b 10
700 1 _ |a Jaunmuktane, Zane
|0 0000-0001-7738-8881
|b 11
700 1 _ |a Spina, Salvatore
|b 12
700 1 _ |a Nelson, Peter T
|b 13
700 1 _ |a Gentleman, Steve
|b 14
700 1 _ |a Alegre-Abarrategui, Javier
|b 15
700 1 _ |a Serrano, Geidy E
|b 16
700 1 _ |a Paes, Vitor Ribeiro
|b 17
700 1 _ |a Takao, Masaki
|b 18
700 1 _ |a Wakabayashi, Koichi
|b 19
700 1 _ |a Uchihara, Toshiki
|b 20
700 1 _ |a Yoshida, Mari
|b 21
700 1 _ |a Saito, Yuko
|b 22
700 1 _ |a Kofler, Julia
|b 23
700 1 _ |a Rodriguez, Roberta Diehl
|b 24
700 1 _ |a Gelpi, Ellen
|0 0000-0003-2948-4187
|b 25
700 1 _ |a Attems, Johannes
|b 26
700 1 _ |a Crary, John F
|0 0000-0002-0556-293X
|b 27
700 1 _ |a Seeley, William W
|b 28
700 1 _ |a Duda, John E
|b 29
700 1 _ |a Keene, C Dirk
|b 30
700 1 _ |a Woulfe, John
|b 31
700 1 _ |a Munoz, David
|b 32
700 1 _ |a Smith, Colin
|b 33
700 1 _ |a Lee, Edward B
|b 34
700 1 _ |a Neumann, Manuela
|0 P:(DE-2719)2810592
|b 35
|u dzne
700 1 _ |a White, Charles L
|b 36
700 1 _ |a McKee, Ann C
|b 37
700 1 _ |a Thal, Dietmar R
|b 38
700 1 _ |a Jellinger, Kurt
|0 0000-0002-9641-7649
|b 39
700 1 _ |a Ghetti, Bernardino
|b 40
700 1 _ |a Mackenzie, Ian R A
|b 41
700 1 _ |a Dickson, Dennis W
|b 42
700 1 _ |a Beach, Thomas G
|0 0000-0003-3296-6128
|b 43
773 _ _ |a 10.1002/mds.30028
|g Vol. 39, no. 12, p. 2173 - 2179
|0 PERI:(DE-600)2041249-6
|n 12
|p 2173 - 2179
|t Movement disorders
|v 39
|y 2024
|x 0885-3185
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/275849/files/DZNE-2025-00084.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/275849/files/DZNE-2025-00084.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:275849
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 35
|6 P:(DE-2719)2810592
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 0
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-16
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MOVEMENT DISORD : 2022
|d 2024-12-16
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2024-12-16
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-16
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-16
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-16
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b MOVEMENT DISORD : 2022
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-16
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2024-12-16
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-16
920 1 _ |0 I:(DE-2719)1210003
|k AG Neumann
|l Molecular Neuropathology of Neurodegenerative Diseases
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1210003
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21